Conditions of MTC in individuals addressed with liraglutide, Yet another GLP-1 receptor agonist, are noted while in the postmarketing period of time; the info in these reports are insufficient to establish or exclude a causal connection involving MTC and GLP-one receptor agonist use in individuals.